• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients.

作者信息

Parsi Mansour A, Lashner Bret A

机构信息

Center for Inflammatory Bowel Disease, Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, USA.

出版信息

Inflamm Bowel Dis. 2004 Jul;10(4):486-7. doi: 10.1097/00054725-200407000-00028.

DOI:10.1097/00054725-200407000-00028
PMID:15475765
Abstract
摘要

相似文献

1
Safety of infliximab: primum non nocere. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients.英夫利昔单抗的安全性：首要原则是不伤害。英夫利昔单抗在克罗恩病患者中的安全性概况：梅奥诊所500例患者的经验。
Inflamm Bowel Dis. 2004 Jul;10(4):486-7. doi: 10.1097/00054725-200407000-00028.
2
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.肛瘘性肛门克罗恩病：手术联合英夫利昔单抗治疗的结果
Dis Colon Rectum. 2006 Dec;49(12):1837-41. doi: 10.1007/s10350-006-0656-5.
3
4
SAFETY PROFILE OF ANTI-TNF THERAPY IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN SINGLE-CENTER DIRECT RETROSPECTIVE COMPARISON BETWEEN INFLIXIMAB AND ADALIMUMAB.抗TNF治疗在克罗恩病管理中的安全性概况：英夫利昔单抗和阿达木单抗在巴西单中心的直接回顾性比较
Arq Gastroenterol. 2017 Dec;54(4):328-332. doi: 10.1590/S0004-2803.201700000-43. Epub 2017 Sep 21.
5
Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience.英夫利昔单抗引入后克罗恩病的治疗费用：单中心英国经验。
Aliment Pharmacol Ther. 2010 Dec;32(11-12):1357-63. doi: 10.1111/j.1365-2036.2010.04482.x. Epub 2010 Oct 7.
6
Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.克罗恩病患者长期英夫利昔单抗治疗的预后因素：一项为期20年的单中心经验
Aliment Pharmacol Ther. 2016 Oct;44(7):673-83. doi: 10.1111/apt.13754. Epub 2016 Aug 9.
7
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.英夫利昔单抗在梅奥诊所临床实践中治疗克罗恩病：首批100例患者
Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x.
8
Serum calprotectin as a biomarker for Crohn's disease.血清钙卫蛋白作为克罗恩病的生物标志物。
J Crohns Colitis. 2013 Dec;7(12):e678-83. doi: 10.1016/j.crohns.2013.06.008. Epub 2013 Jul 9.
9
Evaluation of the infliximab therapy of severe form of pediatric Crohn's disease in Poland: Retrospective, multicenter studies.波兰重度小儿克罗恩病英夫利昔单抗治疗的评估：回顾性多中心研究
Adv Clin Exp Med. 2017 Jan-Feb;26(1):51-56. doi: 10.17219/acem/35802.
10
Methotrexate for induction of remission in refractory Crohn's disease.甲氨蝶呤用于诱导难治性克罗恩病缓解
Cochrane Database Syst Rev. 2012 Dec 12;12:CD003459. doi: 10.1002/14651858.CD003459.pub3.

引用本文的文献

1
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis.溃疡性结肠炎患者报告结局的内镜改善和缓解率。
Aliment Pharmacol Ther. 2020 Feb;51(4):435-445. doi: 10.1111/apt.15577. Epub 2019 Nov 22.
2
Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas.接受脂肪来源的成体干细胞治疗复杂肛周瘘的患者的长期随访。
Int J Colorectal Dis. 2012 May;27(5):595-600. doi: 10.1007/s00384-011-1350-1. Epub 2011 Nov 9.
3
Adipose-derived stem cells in Crohn's rectovaginal fistula.
克罗恩病直肠阴道瘘中的脂肪源性干细胞
Case Rep Med. 2010;2010:961758. doi: 10.1155/2010/961758. Epub 2010 Mar 7.
4
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis.不孕风险增加三倍：溃疡性结肠炎回肠贮袋肛管吻合术后不孕的荟萃分析
Gut. 2006 Nov;55(11):1575-80. doi: 10.1136/gut.2005.090316. Epub 2006 Jun 13.